Drug Trial Radar · NCT06120842
Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution
Last checked: Nov 20, 2026Latest source record: Aug 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
201
Actual
Start
Oct 13, 2023
Primary completion
Jan 31, 2025
Study completion Nov 2027
Sponsor
- Lead sponsor
- SpyGlass Pharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 7, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial is a randomized study to evaluate and compare two doses of the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.
Conditions
- Cataract
- Glaucoma
- Ocular Hypertension
Interventions
Bimatoprost Implant System (High Dose)Drug
Bimatoprost Implant System (High Dose) used in combination with the SpyGlass IOL
Bimatoprost Implant System (Low Dose)Drug
Bimatoprost Implant System (Low Dose) used in combination with the SpyGlass IOL
Timolol Maleate Ophthalmic Solution, 0.5%Drug
Timolol Maleate Ophthalmic Solution 0.5% BID
Commercially Available Aspheric Monofocal Non-Yellow Chromophore IOLDevice
Commercially Available Aspheric Monofocal Non-Yellow Chromophore Intraocular Lens
SpyGlass IOLDevice
SpyGlass Intraocular Lens
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean IOP Reduction from Baseline (mmHg)Time frame: Weeks 2 and 6, and Month 3
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Arizona Advanced Eye Research Institute
Glendale, Arizona
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.